Compare Cart
  • Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Cover Image
Market Research Report
Product code 
347932

Deep Brain Stimulators (DBS) - Medical Devices Pipeline Product Landscape, 2021
Published: | GlobalData | 131 Pages | Delivery time: 1-2 business days

Price

Back to Top
Deep Brain Stimulators (DBS) - Medical Devices Pipeline Product Landscape, 2021
Published: November 15, 2021
GlobalData
Content info: 131 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

GlobalData's Medical Devices sector report, "Deep Brain Stimulators (DBS) - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Deep Brain Stimulators (DBS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A DBS is a device that is comprised of a brain-oriented pacemaker (an implantable pulse generator) that sends electrical stimulation through surgically-implanted electrodes to specific targets in the brain.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Deep Brain Stimulators (DBS) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Deep Brain Stimulators (DBS) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Deep Brain Stimulators (DBS) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date
Product Code: GDME1225EPD

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Deep Brain Stimulators (DBS) Overview

3 Products under Development

  • 3.1 Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
  • 3.2 Deep Brain Stimulators (DBS) - Pipeline Products by Territory
  • 3.3 Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path
  • 3.4 Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date
  • 3.5 Deep Brain Stimulators (DBS) - Ongoing Clinical Trials

4 Deep Brain Stimulators (DBS) - Pipeline Products under Development by Companies

  • 4.1 Deep Brain Stimulators (DBS) Companies - Pipeline Products by Stage of Development
  • 4.2 Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development

5 Deep Brain Stimulators (DBS) Companies and Product Overview

  • 5.1 Actipulse Neuroscience Inc Company Overview
    • 5.1.1 Actipulse Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 Adaptive Neuromodulation GmbH Company Overview
    • 5.2.1 Adaptive Neuromodulation GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 Adept Neuro SA Company Overview
    • 5.3.1 Adept Neuro SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 Aleva Neurotherapeutics SA Company Overview
    • 5.4.1 Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Allegheny Health Network Company Overview
    • 5.5.1 Allegheny Health Network Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 Baylor College of Medicine Company Overview
    • 5.6.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 Bioinduction Limited Company Overview
    • 5.7.1 Bioinduction Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Boston Scientific Corp Company Overview
    • 5.8.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 Brainsway Ltd Company Overview
    • 5.9.1 Brainsway Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 ClearPoint Medical Company Overview
    • 5.10.1 ClearPoint Medical Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 ClearPoint Neuro Inc Company Overview
    • 5.11.1 ClearPoint Neuro Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 Cleveland Medical Devices Inc Company Overview
    • 5.12.1 Cleveland Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 Clinatec Company Overview
    • 5.13.1 Clinatec Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 Deep Brain Innovations, LLC Company Overview
    • 5.14.1 Deep Brain Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 Enspire DBS Therapy Inc Company Overview
    • 5.15.1 Enspire DBS Therapy Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 Fisher Wallace Laboratories, LLC Company Overview
    • 5.16.1 Fisher Wallace Laboratories, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17 Functional Neuromodulation Inc. Company Overview
    • 5.17.1 Functional Neuromodulation Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18 Louisiana State University Company Overview
    • 5.18.1 Louisiana State University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19 Massachusetts General Hospital Company Overview
    • 5.19.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20 Massachusetts Institute of Technology Company Overview
    • 5.20.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21 Medtronic Plc Company Overview
    • 5.21.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22 National Cheng-Kung University Hospital Company Overview
    • 5.22.1 National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23 NeuroOne Inc Company Overview
    • 5.23.1 NeuroOne Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24 Neuroparticle Corp Company Overview
    • 5.24.1 Neuroparticle Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25 NeuroPro Technologies Inc Company Overview
    • 5.25.1 NeuroPro Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26 Neurosigma Inc Company Overview
    • 5.26.1 Neurosigma Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27 Newronika s.r.l. Company Overview
    • 5.27.1 Newronika s.r.l. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28 Nexeon MedSystems Inc Company Overview
    • 5.28.1 Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29 Nia Therapeutics Inc Company Overview
    • 5.29.1 Nia Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
    • 5.30.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31 St. Jude Medical LLC Company Overview
    • 5.31.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32 Sunnybrook Health Sciences Centre Company Overview
    • 5.32.1 Sunnybrook Health Sciences Centre Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33 SUNY Downstate Medical Center Company Overview
    • 5.33.1 SUNY Downstate Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34 University of California Los Angeles Company Overview
    • 5.34.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35 University of California San Francisco Company Overview
    • 5.35.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36 University of Central Florida Company Overview
    • 5.36.1 University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37 University of Florida Company Overview
    • 5.37.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview
  • 5.38 University of Houston Company Overview
    • 5.38.1 University of Houston Pipeline Products & Ongoing Clinical Trials Overview
  • 5.39 University of Illinois Company Overview
    • 5.39.1 University of Illinois Pipeline Products & Ongoing Clinical Trials Overview
  • 5.40 University of Milan Company Overview
    • 5.40.1 University of Milan Pipeline Products & Ongoing Clinical Trials Overview
  • 5.41 University of Oxford Company Overview
    • 5.41.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
  • 5.42 University of Rochester Company Overview
    • 5.42.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
  • 5.43 University of South Florida Company Overview
    • 5.43.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
  • 5.44 Wedge Therapeutics Company Overview
    • 5.44.1 Wedge Therapeutics Pipeline Products & Ongoing Clinical Trials Overview

6 Deep Brain Stimulators (DBS)- Recent Developments

  • 6.1 Nov 08, 2021: Boston Scientific Announces Upcoming Conference Schedule
  • 6.2 Nov 03, 2021: BrainsWay to Report Third Quarter 2021 Financial Results on November 17, 2021
  • 6.3 Oct 27, 2021: Boston Scientific Announces Results For Third Quarter 2021
  • 6.4 Oct 12, 2021: BrainsWay Announces Prominent Addition to Scientific Advisory Board
  • 6.5 Sep 09, 2021: BrainsWay to Participate in Two Upcoming Investor Conferences
  • 6.6 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting
  • 6.7 Jul 28, 2021: BrainsWay to Report Second Quarter 2021 Financial Results on August 11, 2021
  • 6.8 Jul 22, 2021: NeuroPace To Report Second Quarter 2021 Financial Results on August 12, 2021
  • 6.9 Jun 30, 2021: Wise Therapeutics and Soterix Medical jointly announce positive results of study combining Gamified Digital Therapeutics with neurostimulation device
  • 6.10 Jun 03, 2021: NeuroPace Reports First Quarter 2021 Financial Results and Provides 2021 Financial Guidance
  • 6.11 May 24, 2021: Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference
  • 6.12 May 19, 2021: BrainsWay to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit
  • 6.13 May 19, 2021: Avijit Ghosh named interim executive VP for U of I System
  • 6.14 Mar 08, 2021: BrainsWay to Present at the Oppenheimer 31st Annual Healthcare Conference
  • 6.15 Feb 23, 2021: Will Weatherford elected vice chair of the USF Board of Trustees
  • 6.16 Feb 17, 2021: St. Petersburg Conference on World Affairs to provide global perspective and insight into historic turmoil
  • 6.17 Feb 17, 2021: Medtronic Executives to Speak at Upcoming Investor Conferences
  • 6.18 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021
  • 6.19 Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule
  • 6.20 Nov 24, 2020: Griffith researchers develop long-term implantable electronics

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

List of Tables

  • Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
  • Deep Brain Stimulators (DBS) - Pipeline Products by Territory
  • Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path
  • Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date
  • Deep Brain Stimulators (DBS) - Ongoing Clinical Trials
  • Deep Brain Stimulators (DBS) Companies - Pipeline Products by Stage of Development
  • Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
  • Glossary

List of Figures

List of Figures

  • Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
  • Deep Brain Stimulators (DBS) - Pipeline Products by Territory
  • Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path
  • Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date
  • Deep Brain Stimulators (DBS) - Ongoing Clinical Trials